Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease

13 Oct 2017

Abstract excerpt

Chronic graft-versus-host disease (cGVHD) currently represents the leading cause of nonrelapse mortality and morbidity after allogeneic hematopoietic stem cell transplantation (SCT). In parallel with an increased use of granulocyte colony-stimulating factor (G-CSF)-mobilized stem cell products as a graft source, the incidence of cGVHD has dramatically increased. Currently, up to 50% of SCT recipients develop this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation
Share to Mesenchymal stem cell research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29032060
DOI: 10.1016/j.bbmt.2017.10.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging Therapeutics for the Control of Chronic Graft-versus-Host DiseasePMID 29032060Read ↗

Current Challenges in Chronic Graft-versus-Host DiseaseSemantic proximity Read ↗

Chronic Graft-vs-Host DiseaseSemantic proximity Read ↗

Current issues in chronic graft-versus-host diseaseSemantic proximity Read ↗

Graft-versus-host diseaseSemantic proximity Read ↗

Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and TreatmentSemantic proximity Read ↗

Chronic graft-versus-host diseaseSemantic proximity Read ↗

Chronic graft-versus-host disease: A prospective cohort studySemantic proximity Read ↗

New molecules in the therapy of chronic graft-versus-host diseaseSemantic proximity Read ↗

Cellular and molecular mechanisms in graft-versus-host diseaseSemantic proximity Read ↗

Pathophysiology of acute graft-versus-host disease: recent advancesSemantic proximity Read ↗

Evaluating Axatilimab as a treatment option for chronic graft-versus-host diseaseSemantic proximity Read ↗

Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.